Immediate Impact

66 standout
Sub-graph 1 of 22

Citing Papers

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Kally Sidhu being referenced

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
2020
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
2013

Author Peers

Author Last Decade Papers Cites
Kally Sidhu 161 381 107 274 8 514
K. J. Cullen 160 157 361 242 7 621
Aradhana Rani 77 154 265 251 15 577
Gianluigi Bresciani 74 153 174 317 9 525
M. Taton 68 66 330 179 16 630
Carl Simon Shelley 123 282 278 130 13 635
Emma T. Lundsmith 46 156 315 194 7 600
Karen J. Krag 149 214 204 299 11 514
S Lukaszek 140 291 122 337 10 514
Alicia Parkes 457 141 327 307 10 631
Tong-Tong Zou 62 96 280 124 7 470

All Works

Loading papers...

Rankless by CCL
2026